Combining strengths in drug discovery and development by partnering with a medium- or large-sized pharmaceutical company increases the likelihood of success in bringing new products to the market f

Dr. ZhiChao Dang of the National Institute of Public Health and Environment (RIVM) was appointed honorary professor at the highly renowned Nanjing Institute of Environmental Sciences (NIES).

Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).

RIVM has conducted an explorative study on the use of point-of-care (POC) tests in nursing homes.

In personalised medicine, patients are treated with medicinal products according to their individual characteristics, such as genetic background, instead of a traditional one-size-fits-all approach